Chang-Hun obtained his bachelor’s degree in Microbiology from Gyeongsang National University, South Korea. After obtaining his bachelor degree in March 2017, he moved to Konkuk University where he started a Master and Ph.D. program to study synthetic biology approaches under the guidance of Prof. Dr. Hahk-Soo Kang. To complete the thesis, he focused on the development of synthetic biology toolkits for systematic engineering of biosynthetic gene clusters and controlling the production of bioactive secondary metabolites in the genus Streptomyces. At that time, his research project was supported by the Global Ph.D. fellowship of the National Research Foundation of Korea (NRF). He is specially interested in developing genetically engineered microbial strains that can produce the clinically important secondary metabolites such as Daptomycin.
In August 2025, he joined Pierre’s group as a postdoctoral associate where he has applied synthetic biology-based engineering principles to develop therapeutic microbes, combating multidrug-resistant pathogens, and collaboratively worked with the SynThera project team.
